Your browser doesn't support javascript.
loading
Identification and structural analysis of a selective tropomyosin receptor kinase C (TRKC) inhibitor.
Wang, Zhijie; Ren, Jiwei; Jia, Kun; Zhao, Yuming; Liang, Li; Cheng, Zitian; Huang, Fei; Zhao, Xiaofei; Cheng, Jie; Song, Shiyu; Sheng, Tiancheng; Wan, Weiqi; Shu, Qingqing; Wu, Donglin; Zhang, Junhao; Lu, Tao; Chen, Yadong; Ran, Ting; Lu, Shuai.
Afiliación
  • Wang Z; School of Science, China Pharmaceutical University, Nanjing, 211198, PR China.
  • Ren J; School of Science, China Pharmaceutical University, Nanjing, 211198, PR China.
  • Jia K; School of Science, China Pharmaceutical University, Nanjing, 211198, PR China.
  • Zhao Y; Edmond H. Fischer Translational Medical Research Laboratory, Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, 518107, PR China.
  • Liang L; Laboratory of Molecular Design and Drug Discovery, China Pharmaceutical University, Nanjing, 211198, PR China.
  • Cheng Z; School of Science, China Pharmaceutical University, Nanjing, 211198, PR China.
  • Huang F; School of Science, China Pharmaceutical University, Nanjing, 211198, PR China.
  • Zhao X; School of Science, China Pharmaceutical University, Nanjing, 211198, PR China.
  • Cheng J; School of Science, China Pharmaceutical University, Nanjing, 211198, PR China.
  • Song S; School of Life Sciences and Technology, China Pharmaceutical University, Nanjing, 210038, PR China.
  • Sheng T; School of Engineering, China Pharmaceutical University, Nanjing, 211198, PR China.
  • Wan W; School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, PR China.
  • Shu Q; School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, PR China.
  • Wu D; School of Science, China Pharmaceutical University, Nanjing, 211198, PR China.
  • Zhang J; School of Science, China Pharmaceutical University, Nanjing, 211198, PR China.
  • Lu T; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, PR China. Electronic address: lutao@cpu.edu.cn.
  • Chen Y; Laboratory of Molecular Design and Drug Discovery, China Pharmaceutical University, Nanjing, 211198, PR China. Electronic address: chenyadong@gmail.com.
  • Ran T; Drug and Vaccine Research Center, Guangzhou Laboratory, Guangzhou, 510005, PR China. Electronic address: ranting@gzlab.ac.cn.
  • Lu S; School of Science, China Pharmaceutical University, Nanjing, 211198, PR China. Electronic address: lu_shuai@cpu.edu.cn.
Eur J Med Chem ; 241: 114601, 2022 Nov 05.
Article en En | MEDLINE | ID: mdl-35872544
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptor trkC / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Med Chem Año: 2022 Tipo del documento: Article Pais de publicación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptor trkC / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Med Chem Año: 2022 Tipo del documento: Article Pais de publicación: Francia